No Data
Is DexCom a Millionaire-Maker Stock?
Dexcom's Stelo Sees Strong Market Adoption: Justifying a Buy Rating
DexCom Stock Got Crushed After an Earnings Miss. A New Product Could Bail It Out. -- Barrons.com
Morgan Stanley Maintains DexCom(DXCM.US) With Hold Rating, Cuts Target Price to $75
Dexcom Announces Upcoming Conference Presentation
Analysts Conflicted on These Healthcare Names: Quest Diagnostics (DGX), Astrana Health (ASTH) and Dexcom (DXCM)